MedPath

Study of Food Aversion in Patients With Anorexia Nervosa

Not Applicable
Recruiting
Conditions
Anorexia Nervosa
Interventions
Other: A breakfast sandwich
Registration Number
NCT03100656
Lead Sponsor
University of California, San Diego
Brief Summary

This study uses a meal-challenge protocol to assess if patients with anorexia nervosa show a differential metabolism in response to food in comparison to healthy controls. This study determines how heritable and biochemical factors influence food metabolism in anorexia nervosa in order to develop more effective treatment strategies.

Detailed Description

Anorexia nervosa is a brain-based disorder that often leads to serious health consequences including death. The EPHX2 gene has been identified as a susceptibility gene for anorexia nervosa. This study utilizes a multi-omics biomarker system approach to investigate how genetic factors interact with dietary factors to influence food aversion, psychopathology, and clinical outcome in patients with anorexia nervosa.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
300
Inclusion Criteria
  • Ill AN subjects will meet current Diagnostic and Statistical Manual of Mental Disorders (DSM V) diagnosis of AN, body mass index (BMI) between 11 kg/m² and 17.5 kg/m², or BMI > 17.5 kg/m² with active eating disorder symptoms.
  • Recovered AN must meet the following criteria at time of study entry: 1) Current or past DSM V diagnosis of AN; 2) BMI between 18.5 kg/m2 and 30 kg/m2; 3) Having maintained a BMI of >18.5 for at least one year.
  • Control must be healthy adolescent or woman negative on our screen for AN, other Axis I psychiatric illnesses, and having maintained a BMI of between 18.5-30 kg/m² since the age of 18.
Exclusion Criteria
  • Exclusion criteria for AN and control subjects include: Organic brain syndrome, schizophrenia and schizoaffective disorder, untreated thyroid disease, renal disease, hepatic disease, and the regular use of fish-oil containing supplements within the last three months of the study. All pregnant and lactating individuals will be excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Anorexia nervosa IIA breakfast sandwichAnorexia nervosa with BMI \> 18.5 kg/m² for at least 12 months.
Anorexia nervosa IA breakfast sandwichAnorexia nervosa with BMI \<=17.5 kg/m² or BMI \>17.5 kg/m² with regular binge-purge episodes
ControlsA breakfast sandwichHealthy control women
Primary Outcome Measures
NameTimeMethod
Change of metabolism biomarker2 hours

Percentage change of metabolism marker

Food aversion/anxiety2 hours

Percentage change of food aversion/anxiety score

Secondary Outcome Measures
NameTimeMethod
Psychopathology6 and 12 months

Percentage change in eating disorder psychopathology score

Weight6 and 12 months

Change in body weight, kg

Trial Locations

Locations (2)

UC San Diego Altman Clinical and Translational Research Institute

🇺🇸

La Jolla, California, United States

Program for Eating Disorders, Toronto General Hospital

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath